April 26, 2017 2:24 PM ET


Company Overview of Edge Therapeutics, Inc.

Key Executives for Edge Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Brian A. Leuthner 10 RelationshipsCo-Founder, Chief Executive Officer, President and Director51
R. Loch MacDonald M.D., Ph.D.10 RelationshipsCo-Founder, Chief Scientific Officer and Director54
Albert N. Marchio IINo RelationshipsInterim Chief Financial Officer and Chief Accounting & Administrative Officer64
Daniel Brennan 38 RelationshipsChief Operating Officer48
Herbert J. Faleck D.O.No RelationshipsChief Medical Officer63
View More Key Executives

Edge Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sol J. Barer Ph.D. 96 RelationshipsImmunomedics, Inc.69
Brian A. Leuthner 10 RelationshipsEdge Therapeutics, Inc.51
Isaac Blech 86 RelationshipsYuanMing Capital66
R. Loch MacDonald M.D., Ph.D. 10 RelationshipsEdge Therapeutics, Inc.54
Robert S. Langer Jr., Ph.D., Sc.D. 584 RelationshipsPureTech Health plc67
View All Board Members

Edge Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CPAJames J. Loughlin21 Relationships3 Executives
Compensation Committee Ph.D.Sol J. Barer96 Relationships1 Executives
Corporate Governance Committee Isaac Blech86 Relationships2 Executives
Advisory Board Jr., Ph.D., Sc.D.Robert S. Langer584 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$644.9K
Compensation as of Fiscal Year 2015
Edge Therapeutics, Inc. CEO Compensation
Industry Average


Sangamo Announces the Retirement of Edward Lanphier from the Board of Directors
April 25, 2017 8:01 PM ET
Ophthotech Announces Executive Changes
April 25, 2017 2:49 PM ET
Aevi Genomic Medicine, Inc. Announces Retirement of Isaac Blech from the Board of Directors
April 25, 2017 1:00 PM ET
Versartis, Inc. Appoints Jay Stout as Senior Vice President, Technical Operations
April 25, 2017 12:30 PM ET
Cidara Therapeutics, Inc. Appoints Taylor Sandison as Chief Medical Officer
April 25, 2017 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Edge Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.